Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.31 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.31 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.31 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.31 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.31 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.31 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22472138 | 0.88 | PAOX (0.39) | PAOX | |
| SCHEMBL22472148 | 0.88 | PAOX (0.39) | PAOX | |
| SCHEMBL9814628 | 0.87 | TDP1 (0.36) | CHRM1 | |
| SCHEMBL491530 | 0.83 | PAOX (0.35) | PAOXCHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL7729369 | 0.80 | CA12 (0.33) | PAOXCHRM2CHRM4CHRM5CHRM1 | |
| SCHEMBL375727 | 0.80 | CA12 (0.34) | — | |
| SCHEMBL22341 | 0.80 | — | — | |
| SCHEMBL8746116 | 0.78 | TRPA1 (0.32) | — | |
| Ammonia Solution, Strong SCHEMBL28079944 | 0.78 | CA12 (0.33) | — | |
| SCHEMBL9701553 | 0.78 | MCHR1 (0.35) | PAOXCHRM2CHRM4CHRM5CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200353090-A1 | Polymeric prodrugs and subcutaneous and/or intramuscular administration thereof | Universite Paris-Saclay (FR) | 2020-11-12 | — | — | US | claimed |
| EP-3710061-A1 | POLYMER PRODRUGS AND SUBCUTANEOUS AND/OR INTRAMUSCULAR ADMINISTRATION THEREOF | Centre National de la Recherche Scientifique (FR) | 2020-09-23 | — | — | EP | claimed |
| CN-111615405-A | Polymeric prodrugs and subcutaneous and/or intramuscular administration thereof | 国家科学研究中心 | 2020-09-01 | — | — | CN | claimed |
| US-12150996-B2 | Polymeric prodrugs and subcutaneous and/or intramuscular administration thereof | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2024-11-26 | — | — | US | disclosed |
| CN-111615405-B | Polymeric prodrugs and subcutaneous and/or intramuscular administration thereof | 国家科学研究中心 | 2023-11-28 | — | — | CN | disclosed |
| US-20200353090-A1 | Polymeric prodrugs and subcutaneous and/or intramuscular administration thereof | Universite Paris-Saclay (FR) | 2020-11-12 | — | — | US | disclosed |
| US-20200315967-A1 | LIPID NANOPARTICLES | MODERNATX, INC. (US) | 2020-10-08 | — | — | US | disclosed |
| WO-2020196892-A1 | RUBBER COMPOSITION AND METHOD FOR PRODUCING RUBBER COMPOSITION | ＺＳエラストマー株式会社 | 2020-10-01 | — | — | WO | disclosed |
| EP-3710061-A1 | POLYMER PRODRUGS AND SUBCUTANEOUS AND/OR INTRAMUSCULAR ADMINISTRATION THEREOF | Centre National de la Recherche Scientifique (FR) | 2020-09-23 | — | — | EP | disclosed |
| CN-111615405-A | Polymeric prodrugs and subcutaneous and/or intramuscular administration thereof | 国家科学研究中心 | 2020-09-01 | — | — | CN | disclosed |
| WO-2017223135-A1 | LIPID NANOPARTICLES | MODERNATX, INC. (US) | 2017-12-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12150996-B2 | Polymeric prodrugs and subcutaneous and/or intramuscular administration thereof | IDE, SI, PYGM | PAOX 967/4885CHRM2 2230/4885CHRM4 2490/4885 |
| US-20200353090-A1 | Polymeric prodrugs and subcutaneous and/or intramuscular administration thereof | IDE, SI, PYGM | PAOX 972/4885CHRM2 2256/4885CHRM4 2519/4885 |
| US-20200315967-A1 | LIPID NANOPARTICLES | EXOSC9, ABCB4, LIPA | PAOX 341/4885CHRM2 4876/4885CHRM4 4734/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.